30 /100
MEDIUM RISK
Score updated May 30, 2026

CGTX — Cognition Therapeutics, Inc. Dilution Risk Tracker

Track CGTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
19%
🔄 Reverse Split 30%
• 50-day avg $1.11 approaching $1 threshold
🔁 Convertible Conversion 15%
• Convertible debt present: 11.8% potential dilution
🔔 Track CGTX — Get forecast alerts →

💹 Market Data

Market Cap$105.61M
Shares Outstanding89.50M
Float81.85M
Cash$36.81M
Debt$638.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.3% shares (2025Q4 vs prior)
80 institutional holders · 23.54M shares
#1 BIOS Capital Management, LP 6.00M shares
#2 VANGUARD GROUP INC 3.32M shares
#3 DAVENPORT & Co LLC 2.87M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.76M
Days to Cover9.7
% of Float9.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2021
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Feb 18, 2026
4 INSIDER TRANSACTION Feb 18, 2026
4 INSIDER TRANSACTION Feb 18, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CGTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CGTX
📊 CGTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CGTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.